Spots Global Cancer Trial Database for leukemia, lymphocytic, chronic
Every month we try and update this database with for leukemia, lymphocytic, chronic cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors | NCT02440685 | Lymphoma, Large... Lymphoma, Mantl... Lymphoma, Folli... Cancer Neoplasm Tumor Lymphoma, Malig... Lymphoma, B-cel... Lymphoma, Non-H... B-Cell Chronic ... B-Cell Leukemia... B-Lymphocytic L... Chronic Lymphoc... Leukemia, Lymph... Leukemia, Lymph... Myelofibrosis Chronic Idiopat... Idiopathic Myel... Lymphoma, T Cel... Peripheral T-Ce... T-Cell Lymphoma... | ASN002 Dose Esc... ASN002 RD | 18 Years - | Asana BioSciences | |
| Campath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid Malignancies | NCT00038883 | Leukemia, Lymph... Leukemia, Lymph... Lymphoma, Low-G... Lymphoma, T-Cel... Lymphoma, B-Cel... | Campath-1H | 15 Years - 60 Years | M.D. Anderson Cancer Center | |
| Dose-escalation Study of Safety of PBCAR20A in Subjects With r/r NHL or r/r CLL/SLL | NCT04030195 | Non-Hodgkin's L... Chronic Lymphoi... Non-Hodgkin's L... Chronic Lymphoc... Lymphoma, Non-H... Leukemia, Lymph... B-cell Chronic ... B-cell Non Hodg... Small Lymphocyt... | PBCAR20A Fludarabine Cyclophosphamid... | 18 Years - | Precision BioSciences, Inc. | |
| Intermittent Fasting and CLL/SLL | NCT04626843 | Neoplasms Leukemia, Lymph... Lymphoma, Small... Intermittent Fa... Diet Habit Inflammation | Intermittent fa... | 19 Years - 85 Years | British Columbia Cancer Agency | |
| Ibrutinib, Fludarabine, and Pembrolizumab in High-Risk or Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | NCT03204188 | B-Cell Chronic ... B-Lymphocytic L... Chronic Lymphoc... Leukemia, Chron... Leukemia, Chron... Leukemia, Lymph... Leukemia, Lymph... Lymphocytic Leu... Lymphocytic Leu... | Ibrutinib Fludarabine Pembrolizumab | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy | NCT05154474 | Metastatic Canc... Cancer, Breast Cancer Colon Cancer, Rectum Cancer, Lung Cancer Ovaries Cancer Prostate Cancer, Kidney Cancer Pancreas Myeloma Myelodysplasia Leukemia, Myelo... Leukemia,Myeloi... Leukemia, Lymph... Leukemia, Lymph... | Standard | 18 Years - | Weprom | |
| MSC and HSC Coinfusion in Mismatched Minitransplants | NCT01045382 | Leukemia, Myelo... Leukemia, Lymph... Leukemia, Myelo... Myeloproliferat... Myelodysplastic... Multiple Myelom... Leukemia, Lymph... Hodgkin's Disea... Lymphoma, Non-H... | Mesenchymal ste... Isotonic soluti... | - 75 Years | University of Liege | |
| A Safety Study in Patients With Chronic Lymphocytic Leukemia | NCT00283101 | Leukemia, Lymph... | SGN-40 (anti-hu... | 18 Years - | Seagen Inc. | |
| A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms | NCT02842229 | Myelodysplastic... Leukemia Myeloi... Multiple Myelom... Leukemia, Lymph... | 65 Years - | Celgene | ||
| A Safety Study in Patients With Chronic Lymphocytic Leukemia | NCT00283101 | Leukemia, Lymph... | SGN-40 (anti-hu... | 18 Years - | Seagen Inc. | |
| A Phase I/II Trial of Idiotypic Vaccination for Chronic Lymphocytic Leukemia Using a Genetic Approach | NCT00038415 | Leukemia, Lymph... | CLL vaccine usi... | 18 Years - | M.D. Anderson Cancer Center | |
| Rituximab Plus Beta-Glucan in Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma (SLL) | NCT00290407 | Leukemia, Lymph... Lymphoma, Small... | Rituximab Beta-Glucan | 18 Years - | University of Louisville | |
| A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL) | NCT00076401 | Leukemia Leukemia, Lymph... | Motexafin gadol... | 18 Years - | Pharmacyclics LLC. | |
| Study of Forodesine Hydrochloride in Patients With Advanced, Fludarabine-refractory Chronic Lymphocytic Leukemia (CLL) | NCT00289549 | Leukemia, Lymph... | forodesine hydr... | 18 Years - | BioCryst Pharmaceuticals | |
| Study of the Safety and Tolerability of Oral Capsule Form of PCI-24781 in Advanced Cancer Patients | NCT00562224 | Neoplasms by Si... Lymphoma, Non-h... Hodgkin Disease Multiple Myelom... Leukemia, Lymph... | PCI-24781 | 18 Years - | Pharmacyclics LLC. | |
| A Safety Study in Patients With Chronic Lymphocytic Leukemia | NCT00283101 | Leukemia, Lymph... | SGN-40 (anti-hu... | 18 Years - | Seagen Inc. | |
| Post Transplant Donor Lymphocyte Infusion | NCT00167180 | Leukemia, Myelo... Lymphomas Multiple Myelom... Myelodysplastic... Leukemia, Lymph... Leukemia, Lymph... AML | Donor Lymphocyt... Induction Chemo... | 1 Year - 70 Years | Masonic Cancer Center, University of Minnesota | |
| Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL | NCT00546793 | NHL Lymphoma, Non-H... Lymphoma, B-Cel... Lymphoma, Folli... Lymphoma, Inter... Lymphoma, Large... Lymphoma, Low-G... Lymphoma, Mixed... Lymphoma, Small... Leukemia, Lymph... Leukemia, B-Cel... Leukemia, Proly... Leukemia, Small... Lymphoma, Small... Lymphoma, Lymph... Lymphoplasmacyt... CLL SLL | veltuzumab | 18 Years - | Gilead Sciences | |
| Transplantation for Patients With Chronic Lymphocytic Leukemia | NCT00186303 | Leukemia, Lymph... | high dose chemo... ablative alloge... | 18 Years - 60 Years | Stanford University | |
| Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation | NCT00698685 | Leukemia Lymphoma Hodgkin's Disea... Hematologic Neo... Multiple Myelom... Carcinoma, Rena... | Pentostatin Alemtuzumab Allogeneic hema... | 18 Years - 75 Years | University of Arizona | |
| Study of Forodesine Hydrochloride in Patients With Advanced, Fludarabine-refractory Chronic Lymphocytic Leukemia (CLL) | NCT00289549 | Leukemia, Lymph... | forodesine hydr... | 18 Years - | BioCryst Pharmaceuticals | |
| Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor | NCT00393380 | Leukemia, Myelo... Anemia, Aplasti... Myelofibrosis Lymphoma Hodgkin Disease Leukemia, Lymph... Leukemia, Myelo... Leukemia, Lymph... | Parathyroid Hor... | 18 Years - 45 Years | The Emmes Company, LLC | |
| Epoetin Alfa for the Treatment of Anemia Resulting From Chronic Lymphocytic Leukemia | NCT00270049 | Anemia Leukemia, Lymph... Leukemia, Lymph... Cancer Neoplasms Quality of Life | epoetin alfa | 18 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL) | NCT00076401 | Leukemia Leukemia, Lymph... | Motexafin gadol... | 18 Years - | Pharmacyclics LLC. | |
| Dose-escalation Study of Safety of PBCAR20A in Subjects With r/r NHL or r/r CLL/SLL | NCT04030195 | Non-Hodgkin's L... Chronic Lymphoi... Non-Hodgkin's L... Chronic Lymphoc... Lymphoma, Non-H... Leukemia, Lymph... B-cell Chronic ... B-cell Non Hodg... Small Lymphocyt... | PBCAR20A Fludarabine Cyclophosphamid... | 18 Years - | Precision BioSciences, Inc. | |
| Phase III Study Treatment of CLL B and C | NCT00535912 | Leukemia, Lymph... | Stem cells auto... | 18 Years - 60 Years | French Innovative Leukemia Organisation | |
| Post Transplant Donor Lymphocyte Infusion | NCT00167180 | Leukemia, Myelo... Lymphomas Multiple Myelom... Myelodysplastic... Leukemia, Lymph... Leukemia, Lymph... AML | Donor Lymphocyt... Induction Chemo... | 1 Year - 70 Years | Masonic Cancer Center, University of Minnesota | |
| Clofarabine in Chronic Lymphocytic Leukemia | NCT00028418 | Hematologic Neo... Lymphoprolifera... Leukemia Leukemia, Lymph... | Clofarabine | 18 Years - | FDA Office of Orphan Products Development | |
| A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms | NCT02842229 | Myelodysplastic... Leukemia Myeloi... Multiple Myelom... Leukemia, Lymph... | 65 Years - | Celgene | ||
| A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL) | NCT00076401 | Leukemia Leukemia, Lymph... | Motexafin gadol... | 18 Years - | Pharmacyclics LLC. | |
| A Pilot Study of Pivanex in Patients With Chronic Lymphocytic Leukemia | NCT00083473 | Leukemia, Lymph... Lymphoma, Small... | Pivanex | 18 Years - | Titan Pharmaceuticals | |
| Intermittent Fasting and CLL/SLL | NCT04626843 | Neoplasms Leukemia, Lymph... Lymphoma, Small... Intermittent Fa... Diet Habit Inflammation | Intermittent fa... | 19 Years - 85 Years | British Columbia Cancer Agency | |
| A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms | NCT02842229 | Myelodysplastic... Leukemia Myeloi... Multiple Myelom... Leukemia, Lymph... | 65 Years - | Celgene | ||
| Epoetin Alfa for the Treatment of Anemia Resulting From Chronic Lymphocytic Leukemia | NCT00270049 | Anemia Leukemia, Lymph... Leukemia, Lymph... Cancer Neoplasms Quality of Life | epoetin alfa | 18 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| Trial of Ibrutinib Plus Venetoclax Plus Obinutuzumab in Patients With CLL | NCT02758665 | Leukemia, Lymph... | ibrutinib obinutuzumab venetoclax | 18 Years - | University of Ulm |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
